Cullinan Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Cullinan Therapeutics Current Ratio Growth & History (CGEM)
Cullinan Therapeutics's current ratio was 10.25 for fiscal 2025.
View full Cullinan Therapeutics company overviewCullinan Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 10.25 | −3.28 | −24.26% |
| 2024 | 2024-12-31 | 13.53 | −3.54 | −20.72% |
| 2023 | 2023-12-31 | 17.07 | −4.02 | −19.08% |
| 2022 | 2022-12-31 | 21.09 | −4.16 | −16.47% |
| 2021 | 2021-12-31 | 25.25 | 10.42 | +70.32% |
| 2020 | 2020-12-31 | 14.82 | — | — |
Cullinan Therapeutics quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.42 | −1.42 | −14.40% |
| Q1 2026 | 2026-03-31 | 10.28 | −1.34 | −11.52% |
| Q4 2025 | 2025-12-31 | 10.25 | −3.28 | −24.26% |
| Q3 2025 | 2025-09-30 | 10.45 | −14.01 | −57.29% |
| Q2 2025 | 2025-06-30 | 9.83 | −19.04 | −65.94% |
| Q1 2025 | 2025-03-31 | 11.62 | −8.71 | −42.85% |
| Q4 2024 | 2024-12-31 | 13.53 | −3.54 | −20.72% |
| Q3 2024 | 2024-09-30 | 24.46 | 4.13 | +20.29% |
| Q2 2024 | 2024-06-30 | 28.87 | 3.55 | +14.02% |
| Q1 2024 | 2024-03-31 | 20.33 | 5.08 | +33.33% |
| Q4 2023 | 2023-12-31 | 17.07 | −4.02 | −19.08% |
| Q3 2023 | 2023-09-30 | 20.33 | −1.13 | −5.27% |
| Q2 2023 | 2023-06-30 | 25.32 | 15.28 | +152.21% |
| Q1 2023 | 2023-03-31 | 15.25 | −3.43 | −18.37% |
| Q4 2022 | 2022-12-31 | 21.09 | −4.16 | −16.47% |
| Q3 2022 | 2022-09-30 | 21.47 | −20.36 | −48.67% |
| Q2 2022 | 2022-06-30 | 10.04 | −49.94 | −83.26% |
| Q1 2022 | 2022-03-31 | 18.68 | −26.53 | −58.69% |
| Q4 2021 | 2021-12-31 | 25.25 | 10.42 | +70.32% |
| Q3 2021 | 2021-09-30 | 41.82 | — | — |
| Q2 2021 | 2021-06-30 | 59.98 | — | — |
| Q1 2021 | 2021-03-31 | 45.21 | — | — |
| Q4 2020 | 2020-12-31 | 14.82 | — | — |
Cullinan Therapeutics current ratio trends
Over the last five fiscal years, Cullinan Therapeutics's current ratio decreased from 14.82 to 10.25, a change of −4.58. The latest reported quarter, Q2 2026, shows 8.42.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cullinan Therapeutics source filings ↗